Journal article

Epigenetic regulator SMCHD1 functions as a tumor suppressor

HS Leong, K Chen, Y Hu, S Lee, J Corbin, M Pakusch, JM Murphy, IJ Majewski, GK Smyth, WS Alexander, DJ Hilton, ME Blewitt

Cancer Research | Published : 2013

Abstract

SMCHD1 is an epigenetic modifier of gene expression that is critical to maintain X chromosome inactivation. Here, we show in mouse that genetic inactivation of Smchd1 accelerates tumorigenesis in male mice. Loss of Smchd1 in transformed mouse embryonic fibroblasts increased tumor growth upon transplantation into immunodeficient nude mice. In addition, loss of Smchd1 in Em-Myc transgenic mice that undergo lymphomagenesis reduced disease latency by 50% relative to control animals. In premalignant Em-Myc transgenic mice deficient in Smchd1, there was an increase in the number of pre-B cells in the periphery, likely accounting for the accelerated disease in these animals. Global gene expression ..

View full abstract

Grants


Funding Acknowledgements

This work was supported by Fellowships (M.E. Blewitt, I.J. Majewski, G.K. Smyth, W.S. Alexander, and D.J. Hilton) a Program Grant (461219 to W.S. Alexander and D.J. Hilton), and IRIISS support from the Australian National Health and Medical Research Council, Fellowships from the Australian Research Council (M.E. Blewitt and J.M. Murphy), Melbourne University International Research Scholarships (H.S. Leong and K. Chen), an Australian Postgraduate Award (S. Lee), Dyson Bequest funding (M.E. Blewitt), and a Victorian State Government Operational Infrastructure Support Grant.